"Then we can churn out hundreds of millions more of the vaccine".
The health minister stressed that Ukraine is cooperating on all possible global initiatives to ensure that Ukrainians receive the vaccine as soon as possible after it is registered.
"In those individuals who received two doses of the vaccine, they had very similar antibody responses regardless of age by 28 days after that second dose", said Ramasamy.
The Philippines' COVID-19 caseload increased to 413,430 on Thursday, with 1,337 additional infections, the Department of Health said.
Labelled as "ChAdOx1 nCoV-19", the vaccine candidate is an "adenovirus-vectored vaccine", meaning that it consists of engineered viruses that transport a virus' gene (in this case from SARS-Cov-2, the virus which causes the COVID-19 disease) into our bodies.
The comments from Professor Andrew Pollard, study lead from the University of Oxford, per the BBC, come amid news on Thursday that the vaccine induced an immune response, including in participants over age 70, per phase 2 trial data.
This leaves older adults more vulnerable to infection from a variety of illnesses.
On whether the vaccine protects people against Covid-19, he said they were "not there yet" but the data would probably be released "before Christmas".
The Oxford-AstraZeneca Phase II trial reported in The Lancet involved a total of 560 healthy volunteers, with 160 aged 18-55, 160 aged 56-69, and 240 aged 70 or over.
"Up until now, we've looked at antibody, which protects the circulating fluid (blood and tissue flow) from the virus".
Responses were "similar" across all age groups, the researchers said.
"Since elderly populations will be one of the priority groups to receive a vaccine when one is available, this is good news".
Speaking at the 18th edition of Hindustan Times Leadership Summit (HTLS), 2020, Guleria answered a number of questions on the Covid-19 and the vaccine situation in the country.
The summary stated that the purchases of the coronavirus vaccines will be made under Public Procurement Regulatory Authority (PPRA) regulations and its payments will be made in foreign currency.
The Kremlin issued a statement saying Putin and Netanyahu had discussed potential cooperation regarding the Russian vaccine, including supplying it to Israel and even producing it in the Jewish state.
China has been bullish about the development of its vaccine for the new virus, which first emerged in the centre of the country late past year - with four vaccines now in late-stage testing.